Starpharma Holdings (ASX:SPL) Share Price and News - StockTrack

Market Cap (16-May) $36,803,800 (436th)	Close (30-Jun) $0.310 0 (0%)	Volume (30-Jun) 965,700	Shortsold (5-May) 630,735 (0.15%) (400th)
52w High $0.130	52w Low $0.086	P/E 312.50	EPS -0.03

	Subject
	SPL SPL Ann: Change in Director's Interest Notice - J Fairley
	1 (current) 2 3
	SPL SPL Ann: New clinical data for DEP cabazitaxel in prostate cancer
	SPL SPL Ann: S&P DJI Announces September 2022 Quarterly Rebalance
	SPL SPL Ann: Starpharma annual report and full year financial results
	SPL SPL Ann: Appendix 4G - Corporate Governance Statement
	SPL SPL Ann: Starpharma signs new DEP agreement with MSD
	SPL SPL Ann: Quarterly Activities Report & Appendix 4C
	SPL SPL Ann: VIRALEZE Protects Against Omicron in Viral Challenge Model
	SPL SPL Ann: Change in substantial holding
	SPL SPL Ann: VIRALEZE relaunched by LloydsPharmacy in the UK
	SPL SPL Ann: SPL signs expanded DEP research agreement with US Biopharma
	SPL SPL Ann: Shareholder Newsletter
	SPL SPL Ann: Notification of cessation of securities - SPL
	SPL SPL Ann: Application for quotation of securities - SPL
	SPL SPL Ann: SPL7013 in VIRALEZE virucidal against influenza A and B
	SPL SPL Ann: Quarterly Cashflow and Activities Report
	SPL SPL Ann: Change in substantial holding
	SPL SPL Ann: Starpharma to present DEP at Boston ADC summit
	SPL SPL Ann: Dr Jeff Davies appointed as director and Appendix 3X
	SPL SPL Ann: VIRALEZE to relaunch in the UK
	SPL SPL Ann: Application for quotation of securities - SPL
	SPL SPL Ann: Response to media article
	SPL SPL Ann: SPL7013 in VIRALEZE virucidal against Omicron
	SPL SPL Ann: Dr Jeff Davies appointed as non-executive director
	SPL SPL Ann: Interim Report and Half-Year Financial Results
	SPL SPL Ann: VIRALEZE distribution in Saudi Arabia - supplementary info
	SPL SPL Ann: Change in substantial holding
	SPL SPL Ann: VIRALEZE sales and distribution in Saudi Arabia and GCC
	SPL SPL Ann: Application for quotation of securities - SPL
	SPL SPL Ann: Application for quotation of securities - SPL
	SPL SPL Ann: Notification of cessation of securities - SPL
	SPL SPL Ann: Quarterly Cashflow and Activities Report
	SPL SPL Ann: Starpharma receives $7.7M R&D tax incentive refund
	SPL SPL Ann: Notification of cessation of securities - SPL
	SPL SPL Ann: Shareholder Newsletter
	SPL SPL Ann: VIRALEZE antiviral nasal spray registered in Saudi Arabia
	SPL SPL Ann: VIRALEZE successfully launched in Vietnam
	SPL SPL Ann: US Biopharma DEP Research Agreement - Additional Information
	SPL SPL Ann: Starpharma signs DEP Research Agreement with US Biopharma Co
	SPL SPL Ann: Change in Director's Interest Notice - J Fairley
	SPL SPL Ann: Notification regarding unquoted securities - SPL
	SPL SPL Ann: VIRALEZE distribution agreement and launch in Vietnam
	SPL SPL Ann: VIRALEZE registered in Vietnam with launch this week
	SPL SPL Ann: AGM Results
	SPL SPL Ann: AGM Chairman address and CEO presentation
	SPL SPL Ann: Positive DEP phase 2 interim results in prostate cancer
	SPL SPL Ann: Jobkeeper s323DB(1) notice
	SPL SPL Ann: Starpharma to present at Bell Potter Healthcare Conference
	SPL SPL Ann: Application for quotation of securities - SPL
	SPL SPL Ann: Notice of Annual General Meeting/Proxy Form

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

End of Day Prices

Date	Close	Volume	Change
15-May	$0.09	0	0.00 (0.00%)
14-May	$0.09	190,755	0.00 (1.11%)
12-May	$0.09	258,136	0.00 (3.23%)
08-May	$0.09	641,212	0.00 (2.11%)
07-May	$0.10	558,982	+0.00 (1.06%)
05-May	$0.09	24,168	+0.00 (2.17%)
02-May	$0.09	25,000	0.00 (1.08%)
01-May	$0.09	43,456	0.00 (1.06%)
30-Apr	$0.09	118,453	0.00 (0.00%)
28-Apr	$0.09	181,875	+0.01 (5.62%)
24-Apr	$0.09	812,561	-0.01 (7.29%)
17-Apr	$0.10	67,378	0.00 (3.03%)
16-Apr	$0.10	202,222	+0.00 (1.02%)
14-Apr	$0.10	15,014	0.00 (0.00%)
11-Apr	$0.10	5,014	+0.01 (7.69%)
5 up, 7 down, and 3 flat days

High $0.31	Low $0.29	Trades 582	Turnover $291,413	Volume 965,700
30 June 2023 at 4:10pm

High $0.31	Low $0.29	Trades 582	Turnover $291,413	Volume 965,700
30 June 2023 at 4:10pm

Starpharma Holdings Health Care

$0.310 0.030 (10.71%)

$0.310 0.030 (10.71%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices